1. Home
  2. DCGO vs RVNC Comparison

DCGO vs RVNC Comparison

Compare DCGO & RVNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCGO
  • RVNC
  • Stock Information
  • Founded
  • DCGO 2015
  • RVNC 1999
  • Country
  • DCGO United States
  • RVNC United States
  • Employees
  • DCGO N/A
  • RVNC N/A
  • Industry
  • DCGO Managed Health Care
  • RVNC Biotechnology: Pharmaceutical Preparations
  • Sector
  • DCGO Health Care
  • RVNC Health Care
  • Exchange
  • DCGO Nasdaq
  • RVNC Nasdaq
  • Market Cap
  • DCGO 315.9M
  • RVNC 292.5M
  • IPO Year
  • DCGO N/A
  • RVNC 2014
  • Fundamental
  • Price
  • DCGO $3.13
  • RVNC $3.63
  • Analyst Decision
  • DCGO Strong Buy
  • RVNC Buy
  • Analyst Count
  • DCGO 5
  • RVNC 9
  • Target Price
  • DCGO $6.10
  • RVNC $12.00
  • AVG Volume (30 Days)
  • DCGO 1.1M
  • RVNC 2.0M
  • Earning Date
  • DCGO 08-05-2024
  • RVNC 08-06-2024
  • Dividend Yield
  • DCGO N/A
  • RVNC N/A
  • EPS Growth
  • DCGO N/A
  • RVNC N/A
  • EPS
  • DCGO 0.20
  • RVNC N/A
  • Revenue
  • DCGO $703,373,468.00
  • RVNC $236,645,000.00
  • Revenue This Year
  • DCGO $1.59
  • RVNC $20.63
  • Revenue Next Year
  • DCGO N/A
  • RVNC $34.80
  • P/E Ratio
  • DCGO $17.38
  • RVNC N/A
  • Revenue Growth
  • DCGO 61.46
  • RVNC 54.59
  • 52 Week Low
  • DCGO $2.75
  • RVNC $2.30
  • 52 Week High
  • DCGO $10.82
  • RVNC $24.87
  • Technical
  • Relative Strength Index (RSI)
  • DCGO 51.64
  • RVNC 59.63
  • Support Level
  • DCGO $2.75
  • RVNC $3.56
  • Resistance Level
  • DCGO $3.53
  • RVNC $4.38
  • Average True Range (ATR)
  • DCGO 0.15
  • RVNC 0.30
  • MACD
  • DCGO 0.04
  • RVNC 0.12
  • Stochastic Oscillator
  • DCGO 51.28
  • RVNC 61.78

About DCGO DocGo Inc.

DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. The company has three reportable segments: Mobile Health Services, Transportation Services, and Corporate. Mobile Health Services is the key revenue-generating segment for the company.

About RVNC Revance Therapeutics Inc.

Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.

Share on Social Networks: